ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 19, 2014 12:36 JST
Barclays Maintains "Overweight" Rate and Raises the Target Price to US$32.00 on China Mobile Games & Entertainment Group (Nasdaq: CMGE)
HONG KONG, Nov 19, 2014 - (ACN Newswire) - Barclays issued a report on China Mobile Games and Entertainment Group Limited ("CMGE" or the "Company") (Nasdaq: CMGE) on 18th November, 2014. The stock rating maintains "Overweight" and the target price has raised by 3% from US$31.00 to US$32.00.
CMGE delivered another a strong set of results, with 3Q14 total net revenues increasing 265% y/y (30% q/q) to US$58.3mn and GAAP operating margin improving to 20.5% from 15.9% last quarter and -1.9% a year ago, thanks to continued growth in both self-developed games (Joyful Da Yin Jia) and publishing games. With an enriched pipeline coming from diversified acquired game IP, CMGE is aiming to deliver sustainable growth from a higher-quality games portfolio and improve operational efficiency in its game publishing business. Barclays fine-tune the revenue and earnings assumptions to reflect latest pipeline and launch schedule. New price target of US$32 (from US$31) is based on 15x (unchanged) revised 2015E non-GAAP EPADS of US$2.13 (from US$2.10), implying a PEG ratio of 0.28x, which Barclays sees as reasonable considering the strong earnings growth offset by the hit-or-miss nature of new games. Barclays maintains the Overweight rating.
3Q14 revenue breakdown: Management noted that the current revenue split for self-developed and publishing games is 50:50, with the top five games contributing about 60% of the total (Joyful Da Yin Jia ~25%, Super Hero 15%, SanGuoZi 8%).
4Q14 guidance solid, margins improving: CMGE guided 4Q revenues to be US$61.9- US$65.2mn, +159-173% y/y and 6-12% q/q. Gross margin improved to 64.9% in 3Q14, vs 61% in 2Q14 and 58% in 3Q13, mainly due to leverage and stable revenue sharing; non-GAAP operating margin improved to 22.6% Barclays model 4Q14 total revenues at US$64.2mn (+169% y/y) and non-GAAP operating margin at 22%, flat from 22.6% in 3Q14.
Strong pipeline: By successfully securing top game IP such as One-Piece, Naruto, Shaolin Temple and Uncharted Water 5, CMGE's pipeline is getting richer and more diversified. Barclays believes CMGE has proven its ability to execute and operate multiple successful games on its platform. As more new games are slated to be released in 2015, Barclays expect CMGE to leverage its publishing position to capture the strong growth prospects of online games.
Sectors: Daily Finance, IT Individual, Daily News
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event
Sep 03, 2025 12:30 JST
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Sep 03, 2025 11:32 JST
Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025
Sep 03, 2025 11:00 JST
Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure
Sep 03, 2025 10:58 JST
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT
Sep 02, 2025 12:50 JST
Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework "SAFe(R)"
Sep 02, 2025 11:50 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Sep 01, 2025 22:28 JST
DENSO Signs Agreement to Transfer Part of Its Ceramic Product Business
Sep 01, 2025 20:52 JST
Honda to Provide Official Vehicles for World Athletics Championships Tokyo 25 as Official Global Partner
Sep 01, 2025 13:50 JST
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Sep 01, 2025 13:44 JST
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) - Applications for Research Projects Open on September 1
Sep 01, 2025 11:00 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Aug 29, 2025 20:39 JST
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building
Aug 29, 2025 18:54 JST
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma
Aug 29, 2025 18:17 JST
Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage
Aug 29, 2025 15:17 JST
Hong Kong Watch & Clock Fair, Salon de TIME return in September
Aug 28, 2025 21:27 JST
SenseTime Announces 2025 Interim Results
Aug 28, 2025 21:20 JST
Ausnutria 2025 Interim Results Announcement: Revenue and Profit Maintain Resilient Dual Growth
Aug 28, 2025 19:09 JST
Baguio Green Group (1397.HK) Announces 2025 Interim Results
Aug 28, 2025 19:03 JST
Production, Sales and Export Results for July, 2025
Aug 28, 2025 17:36 JST
More Latest Release >>